Search research articles
Contact Us
Filters
Showing results (11-20 of 75) with videos related to
Page
of 8
Sort By:
Drug Discovery Today
|
October 9, 2020
A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
Danielle Nader, Gerard F Curley, Steven W Kerrigan
Intensive Care Medicine
|
December 3, 2015
What's new in cell therapies in ARDS?
Shahd Horie, Gerard F Curley, John G Laffey
The Journal of Physiology
|
June 5, 2013
CrossTalk proposal: there is added benefit to providing permissive hypercapnia in the treatment of ARDS
Gerard F Curley, John G Laffey, Brian P Kavanagh
Intensive Care Medicine Experimental
|
July 27, 2019
Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns
Claire H Masterson, Gerard F Curley, John G Laffey
Anesthesiology
|
August 27, 2009
Mechanical ventilation: taking its toll on the lung
Gerard F Curley, Leo G Kevin, John G Laffey
The Journal of Physiology
|
June 5, 2013
Rebuttal from Gerard F. Curley, John G. Laffey and Brian P. Kavanagh
Gerard F Curley, John G Laffey, Brian P Kavanagh
Current Stem Cell Research & Therapy
|
March 5, 2014
Therapeutic potential and mechanisms of action of mesenchymal stromal cells for Acute Respiratory Distress Syndrome
Gerard F Curley, Jeremy A Scott, John G Laffey
The Canadian Journal of Cardiology
|
December 28, 2016
The Swan-Ganz Catheter Remains a Critically Important Component of Monitoring in Cardiovascular Critical Care
Matthew Lee, Gerard F Curley, Mary Mustard, et al.
Plos One
|
June 23, 2021
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19
Danielle Nader, Nicola Fletcher, Gerard F Curley, et al.
Intensive & Critical Care Nursing
|
March 22, 2024
Pressure ulcer risk assessment in the ICU. Is it time for a more objective measure?
Natalie L McEvoy, Declan Patton, Gerard F Curley, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 75) with videos related to
Sort By:
Page
of 8
Drug Discovery Today
|
October 9, 2020
A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
Danielle Nader, Gerard F Curley, Steven W Kerrigan
Intensive Care Medicine
|
December 3, 2015
What's new in cell therapies in ARDS?
Shahd Horie, Gerard F Curley, John G Laffey
The Journal of Physiology
|
June 5, 2013
CrossTalk proposal: there is added benefit to providing permissive hypercapnia in the treatment of ARDS
Gerard F Curley, John G Laffey, Brian P Kavanagh
Intensive Care Medicine Experimental
|
July 27, 2019
Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns
Claire H Masterson, Gerard F Curley, John G Laffey
Anesthesiology
|
August 27, 2009
Mechanical ventilation: taking its toll on the lung
Gerard F Curley, Leo G Kevin, John G Laffey
The Journal of Physiology
|
June 5, 2013
Rebuttal from Gerard F. Curley, John G. Laffey and Brian P. Kavanagh
Gerard F Curley, John G Laffey, Brian P Kavanagh
Current Stem Cell Research & Therapy
|
March 5, 2014
Therapeutic potential and mechanisms of action of mesenchymal stromal cells for Acute Respiratory Distress Syndrome
Gerard F Curley, Jeremy A Scott, John G Laffey
The Canadian Journal of Cardiology
|
December 28, 2016
The Swan-Ganz Catheter Remains a Critically Important Component of Monitoring in Cardiovascular Critical Care
Matthew Lee, Gerard F Curley, Mary Mustard, et al.
Plos One
|
June 23, 2021
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19
Danielle Nader, Nicola Fletcher, Gerard F Curley, et al.
Intensive & Critical Care Nursing
|
March 22, 2024
Pressure ulcer risk assessment in the ICU. Is it time for a more objective measure?
Natalie L McEvoy, Declan Patton, Gerard F Curley, et al.
Page
of 8